Management of puberty in growth hormone deficient children.
The pubertal growth spurt accounts for approximately one-eighth of adult height and is regulated by complex hormonal interactions involving the somatotropic and gonadal axes. The observation that children with growth hormone deficiency (GHD) may fail to achieve an appropriate pubertal growth spurt led to the development of strategies to optimize GH therapy during puberty. In one strategy the dosage of GH is increased during puberty to support pubertal growth and in keeping with the physiological increase in serum levels of the hormone seen at that age. A different approach is to combine a GnRH analog (GnRHa) to GH to stop pubertal development, delaying epiphyseal fusion and prolonging peripubertal growth. Both strategies require caution. As regards the first strategy, too high doses of GH may shorten the pubertal time for growth; we found a small, nonsignificant, improvement in final height by increasing the dose by less than half. Preliminary results on the second strategy are more encouraging. However, manipulation of puberty should be limited to selected patients who show a statural height SDS for bone age unfavorable in terms of height prognosis.
Saggese
G
G
Department of Reproductive Medicine and Pediatrics, University of Pisa, Italy.
Federico
G
G
Barsanti
S
S
D000293:Adolescent; D001827:Body Height / Q000187:drug effects; D002648:Child; D004359:Drug Therapy, Combination; D004393:Dwarfism, Pituitary / Q000188:drug therapy* / Q000503:physiopathology; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000172:deficiency / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D011627:Puberty / Q000187:drug effects* / Q000502:physiology
D019382:Human Growth Hormone; D007987:Gonadotropin-Releasing Hormone